Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-16

Clinical Trial Update: The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of probiotics on symptoms and intestinal flora in patients with Irritable Bowel Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotics

Snippet

Sponsor: Probi AB | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED